67 results
8-K
EX-10.1
MTNB
Matinas Biopharma Holdings Inc
5 Apr 24
Matinas BioPharma Announces Registered Direct Offering of $10 Million
7:00am
8-K
EX-10.1
dabubckuh5epl
25 Feb 19
Prominent Cardiovascular Expert, James J. Ferguson, M.D., FACC, FAHA Joins Matinas BioPharma as Chief Medical Officer
8:15am
8-K
EX-10.1
ihpiiqc
3 Jan 19
Matinas BioPharma Appoints Keith A. Kucinski, CPA, MBA as Chief Financial Officer
8:05am
8-K
EX-10.1
bklcbu9sh2ealy
15 Oct 18
Departure of Directors or Certain Officers
8:00am
8-K
EX-10.1
485h63fgg7g4ui1mc
19 Jun 18
Matinas BioPharma Announces Pricing of $8.0 Million Public Offering
5:19pm
8-K
EX-10.1
l5asl65i lm
27 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
e6wwnlwa l11nwgr8s4
28 Apr 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
dx3q9m6vi9eai0ym7
18 Apr 17
Matinas BioPharma Appoints Dominick DiPaolo as Senior Vice President of Quality and Regulatory Compliance
12:00am